Neuphoria Therapeutics, Inc. (NEUP)

3.89 +0.09 (+2.37%) USD  |  NASDAQ  |  Dec 18, 16:00
3.85 -0.04 (-1.03%) Pre-Market: 08:35
More

Neuphoria Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for NEUP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Adverum Biotechnologies, Inc. Upgrade
Aditxt, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
X4 Pharmaceuticals, Inc. Upgrade
Inhibrx Biosciences, Inc. --